Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.
Fossella
F V
FV
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Lippman
S M
SM
Seitz
D E
DE
Alberts
D S
DS
Taylor
C W
CW
Wiltshaw
E
E
Hardy
J
J
O'Brien
M
M
Haynes
T R
TR
Wolen
R L
RL
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy* / Q000556:secondary; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004341:Drug Evaluation; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*; D014859:Warfarin / Q000008:administration & dosage*
D013453:Sulfonylurea Compounds; D014859:Warfarin; C058179:sulofenur